在MDR-TB患者中停止使用线索利德后视觉恢复:详细的病例分析
Yovil Bagas Wiyana1, Isnin Anang Marhana1, Gatot Suhartono2
1Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Airlangga-Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Case reports in pulmonology
|August 4, 2025
概括
线索利德是治疗多耐药结核病 (MDR-TB) 的抗生素,可引起视神经病变,导致视力丧失. 终止线索利德治疗允许逐渐改善视力,突出显示需要监测眼部毒性.
科学领域:
- 眼科医生 眼科 眼科
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐多药结核病 (MDR-TB) 需要复杂的治疗方案.
- 莱涅佐利德是MDR-TB的关键抗生素,但具有眼睛毒性的风险.
- 视神经病变是已知的linezolid的副作用,通常表现为视力丧失.
研究的目的:
- 在患有MDR-TB的患者中报告linezolid诱导的视神经病变病例.
- 为了强调眼科监测在长时间的linezolid治疗期间的重要性.
- 突出药物戒断后可逆视力丧失的可能性.
主要方法:
- 一个47岁的男性患者的案例研究,患有复发性MDR-TB.
- 治疗方案包括levofloxacin,linezolid,clofazimine和cycloserine. 这三种药物是最常见的.
- 进行了眼科检查,包括OCT和MRI. 由于视力障碍,莱涅佐利德的治疗已停止.
主要成果:
- 患者在线索利德治疗9个月后出现了渐进的视力障碍.
- 眼科评估证实光神经病变没有内病理.
- 尽管最初接受了类固醇治疗,但在停止使用linezolid后,视力逐渐得到改善.
结论:
- 在患有MDR-TB的患者中,莱涅佐利德可以引起可逆性视神经病变.
- 定期的眼科评估对于长期服用linezolid的患者至关重要.
- 及时停止使用线索利德可以防止永久性视力损伤.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
239
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
239
Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis II
352
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
352
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis III
445
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
445


